IQV
IQVIA HOLDINGS INC.
NYSE · Healthcare · Medical - Diagnostics & Research · US
$262.32
−0.10%Year over year
Reported trailing growth
- Revenue
- +8.8%
- EBITDA
- +4.7%
- EBIT
- +6.6%
- EPS
- +13.2%
- Free cash flow
- -21.3%
- Operating cash flow
- -2.4%
Forward estimates
Based on analyst estimates
- Revenue
- +5.4%
- EBITDA
- +31.3%
- EPS
- +66.0%
Three-year CAGR
- Revenue
- +4.2%
- EBITDA
- +0.3%
- EBIT
- +6.6%
- Net income
- +7.6%
- EPS
- +10.8%
- Free cash flow
- +8.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026